Clinical audit of rectal cancer patient referrals for Papillon contact brachytherapy

Baker, A, Buckley, L, Misra, V and Bridge, P
(2020) Clinical audit of rectal cancer patient referrals for Papillon contact brachytherapy. Journal of Radiotherapy in Practice, 19 (4). 321 - 326.

This is the latest version of this item.

[img] Text
Author Accepted Version.pdf - Accepted Version

Download (627kB) | Preview
[img] Text
clinical_audit_of_rectal_cancer_patient_referrals_for_papillon_contact_brachytherapy.pdf - OA Published Version

Download (257kB) | Preview


<jats:title>Abstract</jats:title><jats:sec id="S1460396919000803_as1"><jats:title>Background and purpose:</jats:title><jats:p>Papillon treatment is a form of contact X-ray brachytherapy (CXB) which is used as an alternative to surgery for rectal cancer. This study aimed to audit patients who were referred for and treated with CXB over a 6-year period against guidelines derived from a critical review of the evidence base.</jats:p></jats:sec><jats:sec id="S1460396919000803_as2"><jats:title>Materials and methods:</jats:title><jats:p>Patient demographics, tumour characteristics and outcome data were gathered for 31 patients referred for CXB. A critical review of the evidence identified consensus referral criteria and outcome data against which to audit patients.</jats:p></jats:sec><jats:sec id="S1460396919000803_as3"><jats:title>Results:</jats:title><jats:p>Referral criteria were derived from six published studies. These applied to patients unfit for surgery or stoma-averse. All referred patients had a visible tumour or scar with a tumour size under 3 cm and sited less than 12 cm from the anal verge. Nodal status varied from N0 to N2, but there was no metastatic disease present. The audited cohort demonstrated demographic equivalence, while the initial clinical complete response and recurrence rates were also comparable.</jats:p></jats:sec><jats:sec id="S1460396919000803_as4"><jats:title>Conclusion:</jats:title><jats:p>This audit confirmed the validity of referral and treatment protocols and should guide future referrals until evidence from ongoing studies becomes available. These findings should contribute to the development of robust national guidelines.</jats:p></jats:sec>

Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 14 Jan 2020 10:56
Last Modified: 03 Apr 2021 21:10
DOI: 10.1017/s1460396919000803
Open Access URL:

Available Versions of this Item